MedTrace Logo

Combined Segmentectomy Versus Lobectomy for Stage IA Lung Adenocarcinoma With Ground-glass Component of Prospective, Randomized, Controlled Clinical Study

NCT05983835 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 688

Last updated 2023-08-09

No results posted yet for this study

Summary

This project intends to include stage IA lung adenocarcinoma patients with CT imaging grboreal lesions; compare the results of lobectomy vs combined subsegmentectomy, and compare perioperative complications, differences in lung function and long-term outcomes between the two groups.

Conditions

  • IA Lung Adenocarcinoma
  • Combined Segmentectomy

Interventions

PROCEDURE

Patients receive subsegmentectomy

Patients receive lobectomy

Sponsors & Collaborators

  • Wu Jieping Medical Foundation

    collaborator OTHER

  • Fujian Medical University Union Hospital

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
20 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-10-01
Primary Completion
2024-10-01
Completion
2025-10-01

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05983835 on ClinicalTrials.gov